NCT02811146

Brief Summary

The study aims to demonstrate the efficacy of NIV continuously in cardiac rehabilitation programs, improvement of exercise tolerance, with consequent reflection in functional capacity and quality of life of this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable heart-failure

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable heart-failure

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 23, 2016

Completed
8 days until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

October 5, 2021

Status Verified

October 1, 2021

Enrollment Period

4.9 years

First QC Date

June 2, 2016

Last Update Submit

October 4, 2021

Conditions

Keywords

Heart FailureNoninvasive VentilationPositive- Pressure Respiration

Outcome Measures

Primary Outcomes (4)

  • Cardiopulmonary exercise testing

    Change in functional capacity

    Baseline and 12 weeks

  • Glittre-ADL Test

    Change in submaximal functional capacity

    Baseline and 12 weeks

  • Six-Minute Walk Test

    Change in submaximal functional capacity

    Baseline

  • Ventilatory metabolic response during the 6-minute walk test (6MWT) and Glittre-ADL Test

    Compare the ventilatory metabolic response of the six-minute walk test and Glittre-ADL Test

    Baseline and 12 weeks

Secondary Outcomes (2)

  • Minnesota Living with Heart Failure

    Baseline and 12 weeks

  • Bioimpedance scale

    Baseline and 12 weeks

Study Arms (6)

Cardiopulmonary exercise testing

EXPERIMENTAL

Assess whether people who wore noninvasive ventilation during aerobic exercise have greater functional capacity than those who did not wear.

Device: Bilevel Positive Pressure AirwayOther: Heart rehabilitation

ADL Glitre test

EXPERIMENTAL

Check that people who wore noninvasive ventilation during aerobic exercise have greater submaximal functional capacity than those who did not wear. Compare a ventilatory metabolic response of the ADL Glitre test with an six-minute walk test. .

Device: Bilevel Positive Pressure AirwayOther: Heart rehabilitation

Minnesota Living with Heart Failure

EXPERIMENTAL

Check if people undergoing heart rehabilitation has improved quality of life.

Device: Bilevel Positive Pressure AirwayOther: Heart rehabilitation

Bioimpedance balance

EXPERIMENTAL

Check if people undergoing heart rehabilitation has improved the body composition.

Device: Bilevel Positive Pressure AirwayOther: Heart rehabilitation

Six-minute walk test

NO INTERVENTION

Compare a ventilatory metabolic response of the six-minute walk test with an ADL Glitre test.

Metabolic ventilatory response

EXPERIMENTAL

To verify if non-invasive ventilation during aerobic exercise modifies the ventilatory metabolic response in patients with heart failure. Check the metabolic ventilatory response during the Glittre ADL test and six-minute walk test.

Device: Bilevel Positive Pressure AirwayOther: Heart rehabilitation

Interventions

Heart rehabilitation with noninvasive ventilation, for 12 weeks, 3 times a week

ADL Glitre testBioimpedance balanceCardiopulmonary exercise testingMetabolic ventilatory responseMinnesota Living with Heart Failure

Heart rehabilitation, for 12 weeks, 3 times a week

ADL Glitre testBioimpedance balanceCardiopulmonary exercise testingMetabolic ventilatory responseMinnesota Living with Heart Failure

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sedentary adults diagnosed with heart failure of ischemic hypertensive or alcoholic etiology;
  • Ejection fraction of the left ventricle smaller than 50% (LVEF \<50%) assessed by echocardiography simple;
  • Recent and functional class II and III by the New York Heart Association (NYHA);
  • FEV1 \<80% predicted and / or FEV1 / FVC\> 70% predicted;
  • Clinical stability; Ex-smokers for more than five years;
  • No change in the class of drugs within three months prior to the beginning of the study.

You may not qualify if:

  • Patients with unstable angina;
  • Myocardial infarction or heart surgery up to three months before the survey;
  • FEV1 / FVC \<70% predicted characterizing obstructive respiratory disorder;
  • Respiratory diseases;
  • Smoking;
  • Hemodynamic instability;
  • Trauma of recent face;
  • Nausea and vomiting;
  • Orthopedic and neurological diseases;
  • Psychic changes that restrict them to respond to the questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital of the Clinics Federal University of Pernambuco

Recife, Pernambuco, 50670-901, Brazil

Location

Cardiopulmonary Physiotherapy Laboratory

Recife, Pernambuco, 50740-560, Brazil

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Continuous Positive Airway PressureCardiac Rehabilitation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory TherapyRehabilitationAftercareContinuity of Patient CarePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physiotherapist, clinical research

Study Record Dates

First Submitted

June 2, 2016

First Posted

June 23, 2016

Study Start

July 1, 2016

Primary Completion

May 31, 2021

Study Completion

July 1, 2021

Last Updated

October 5, 2021

Record last verified: 2021-10

Locations